ASPIRE Obstetric Anesthesia Subcommittee Meeting
May 24, 2023
Agenda
Announcements
February 2023 Meeting Recap
GA-01 & GA-02 Measure Exclusion: Placenta Accreta
Measure Review: ABX-01
BMI Stratification
Use of Second Line Uterotonic Agents
Introductions
Welcome new members:
• Brigham and Women's – Lawrence Tsen and Sharon Reale
• Dartmouth - Johanna Cobb (Congrats to Dr. Joshi on her retirement!)
• Baylor- Uma Munnur and Sonal Zambare
• UCLA –Brittany Burton
• Yale- Aymen Alian
Please introduce yourself: Name, Role, Institution
Announcements
OB Subcommittee Virtual Meeting:
• November 15, 2023 1pm EST
MPOG Retreat
• October 13, 2023 San Francisco, CA
February Meeting Recap
• Last meeting held on February 15
th.
Slides and recording posted to basecamp
.
• ABX-01 QI story shared by Dr. Robert Nicholson from Bronson-Kalamazoo.
• Dr. Mike Mathis, MPOG Research Director shared a brief overview of the PCRC process for
those interested in conducting research using MPOG data. Please visit the MPOG website for
steps to begin your proposal:
https://mpog.org/write-a-research-proposal/
• Reviewed oxytocin survey results and determined there is wide variation in oxytocin dosages
and rates of administration across sites. More research needed in this area before
standardization can occur.
Measure Updates
GA-03-OB – On your dashboards now!
Percentage of cesarean delivery cases where general anesthesia was
administered after epidural injection.
Measure Spec-
• Departmental only measure
• No threshold, outcome measure lower scores = better
performance
• Not available for individual provider feedback emails
In the News: Oxytocin labeling practice
• Recent article about Oxytocin
labels with follow-up Twitter
conversation
• What do your labels look like?
MPOG Social Media
Twitter @mpogaspire
LinkedIn – Multicenter Perioperative Outcomes Group
Oxytocin Labeling Practice
GA 01 & GA-02- Discussion for New Exclusion
GA-01-OB- Cesarean Delivery cases where General Anesthesia was used.
GA-02-OB- Percentage of Cesarean Delivery cases where General Anesthesia was
Administered after Neuraxial Anesthesia.
Current Exclusions:
– GA-01 - Cesarean Hysterectomies & Non-cesarean delivery cases
– GA-02 – Cesarean Hysterectomies, Non-cesarean delivery cases, Cesarean delivery cases
that only use general anesthesia without neuraxial anesthesia
Moving forward, should we exclude Placenta Accreta cases from these measures?
ABX-01-OB Current Performance
Cesarean delivery cases with antibiotic administration within one hour before surgical
incision
Measure review
• BP-04 will be reviewed at the November meeting.
• The measure review schedule is posted on Basecamp. Please also check your
emails for the measure review schedule.
• Template form
Measure
Published
date
Present at OB
subcommittee
Assigned to
ABX-01
July 2020
May 2023
Monica Servin and Brandon Togioka
BP-04
Feb 2021
Nov 2023
Preet Singh and Dan Biggs
GA-01
Feb 2021
Feb 2024
Melinda Mitchell and Sharon Abramovitz
GA-02
Aug 2021
Feb 2024
Melinda
and Sharon
TEMP-05
Aug 2021
Feb or May 2024
Wandana Joshi and Christine Warrick
THANK YOU!
Nicole Barrios MHA, BSN-RN
Obstetric Anesthesia Subcommittee Lead
nicbarri@med.umich.edu
Monica Servin, MD
MPOG Obstetric Anesthesia
Subcommittee Chair
monicar@med.umich.edu
